nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Ulcer—Mercaptopurine—Crohn's disease	0.0232	0.0534	CcSEcCtD
Pentazocine—Drug dependence—Prednisone—Crohn's disease	0.0227	0.0523	CcSEcCtD
Pentazocine—OPRD1—Peptide GPCRs—CCR9—Crohn's disease	0.0144	0.0255	CbGpPWpGaD
Pentazocine—OPRK1—Peptide GPCRs—CCR9—Crohn's disease	0.0126	0.0224	CbGpPWpGaD
Pentazocine—Hepatic function abnormal—Azathioprine—Crohn's disease	0.0109	0.025	CcSEcCtD
Pentazocine—OPRM1—Peptide GPCRs—CCR9—Crohn's disease	0.0107	0.0189	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.0103	0.0183	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00979	0.0173	CbGpPWpGaD
Pentazocine—Disorientation—Mesalazine—Crohn's disease	0.00968	0.0223	CcSEcCtD
Pentazocine—OPRD1—Peptide GPCRs—CCR6—Crohn's disease	0.00955	0.0169	CbGpPWpGaD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00953	0.0169	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00905	0.016	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00858	0.0152	CbGpPWpGaD
Pentazocine—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00856	0.0197	CcSEcCtD
Pentazocine—OPRK1—Peptide GPCRs—CCR6—Crohn's disease	0.00838	0.0148	CbGpPWpGaD
Pentazocine—Face oedema—Mesalazine—Crohn's disease	0.00836	0.0192	CcSEcCtD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00811	0.0143	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00808	0.0143	CbGpPWpGaD
Pentazocine—Abdominal discomfort—Azathioprine—Crohn's disease	0.00788	0.0181	CcSEcCtD
Pentazocine—Cramp muscle—Mesalazine—Crohn's disease	0.0078	0.0179	CcSEcCtD
Pentazocine—OPRM1—Peptide ligand-binding receptors—ACKR2—Crohn's disease	0.00765	0.0135	CbGpPWpGaD
Pentazocine—Anorexia—Mercaptopurine—Crohn's disease	0.00748	0.0172	CcSEcCtD
Pentazocine—Eosinophilia—Mesalazine—Crohn's disease	0.00741	0.017	CcSEcCtD
Pentazocine—OPRM1—Peptide ligand-binding receptors—MLN—Crohn's disease	0.00725	0.0128	CbGpPWpGaD
Pentazocine—Abdominal discomfort—Mesalazine—Crohn's disease	0.00718	0.0165	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00709	0.0125	CbGpPWpGaD
Pentazocine—OPRM1—Peptide GPCRs—CCR6—Crohn's disease	0.00708	0.0125	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00692	0.0123	CbGpPWpGaD
Pentazocine—Agranulocytosis—Azathioprine—Crohn's disease	0.00684	0.0157	CcSEcCtD
Pentazocine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00682	0.0157	CcSEcCtD
Pentazocine—OPRD1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00678	0.012	CbGpPWpGaD
Pentazocine—Ulcer—Prednisone—Crohn's disease	0.00667	0.0153	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00656	0.0116	CbGpPWpGaD
Pentazocine—Sweating—Mesalazine—Crohn's disease	0.0064	0.0147	CcSEcCtD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00631	0.0112	CbGpPWpGaD
Pentazocine—Agranulocytosis—Mesalazine—Crohn's disease	0.00623	0.0143	CcSEcCtD
Pentazocine—Erythema multiforme—Azathioprine—Crohn's disease	0.00622	0.0143	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00607	0.0107	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00599	0.0106	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00595	0.0105	CbGpPWpGaD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00591	0.0105	CbGpPWpGaD
Pentazocine—Chills—Azathioprine—Crohn's disease	0.0059	0.0136	CcSEcCtD
Pentazocine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00578	0.0133	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00576	0.0102	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00572	0.0101	CbGpPWpGaD
Pentazocine—Erythema multiforme—Mesalazine—Crohn's disease	0.00567	0.013	CcSEcCtD
Pentazocine—Tinnitus—Mesalazine—Crohn's disease	0.00559	0.0128	CcSEcCtD
Pentazocine—Euphoric mood—Prednisone—Crohn's disease	0.00542	0.0125	CcSEcCtD
Pentazocine—Chills—Mesalazine—Crohn's disease	0.00538	0.0124	CcSEcCtD
Pentazocine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00537	0.0123	CcSEcCtD
Pentazocine—OPRM1—IL4-mediated signaling events—SOCS1—Crohn's disease	0.00536	0.00949	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00531	0.0094	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—ACKR2—Crohn's disease	0.00527	0.00933	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—IL17A—Crohn's disease	0.00525	0.00929	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00513	0.00908	CbGpPWpGaD
Pentazocine—Dysgeusia—Mesalazine—Crohn's disease	0.00511	0.0117	CcSEcCtD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CCR9—Crohn's disease	0.00503	0.0089	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00502	0.00888	CbGpPWpGaD
Pentazocine—Muscle spasms—Mesalazine—Crohn's disease	0.00501	0.0115	CcSEcCtD
Pentazocine—OPRD1—GPCR ligand binding—MLN—Crohn's disease	0.005	0.00885	CbGpPWpGaD
Pentazocine—Vomiting—Mercaptopurine—Crohn's disease	0.00499	0.0115	CcSEcCtD
Pentazocine—Dermatitis—Mercaptopurine—Crohn's disease	0.00494	0.0114	CcSEcCtD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00494	0.00874	CbGpPWpGaD
Pentazocine—Vision blurred—Mesalazine—Crohn's disease	0.00492	0.0113	CcSEcCtD
Pentazocine—Tremor—Mesalazine—Crohn's disease	0.00489	0.0112	CcSEcCtD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00486	0.00861	CbGpPWpGaD
Pentazocine—OPRM1—IL4-mediated signaling events—IL10—Crohn's disease	0.00481	0.00851	CbGpPWpGaD
Pentazocine—Vertigo—Mesalazine—Crohn's disease	0.00469	0.0108	CcSEcCtD
Pentazocine—Syncope—Mesalazine—Crohn's disease	0.00468	0.0108	CcSEcCtD
Pentazocine—Nausea—Mercaptopurine—Crohn's disease	0.00466	0.0107	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00466	0.00824	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—RIPK2—Crohn's disease	0.00465	0.00824	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—ACKR2—Crohn's disease	0.00462	0.00818	CbGpPWpGaD
Pentazocine—Loss of consciousness—Mesalazine—Crohn's disease	0.00458	0.0105	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00455	0.00805	CbGpPWpGaD
Pentazocine—Hypertension—Mesalazine—Crohn's disease	0.0045	0.0104	CcSEcCtD
Pentazocine—OPRD1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00449	0.00795	CbGpPWpGaD
Pentazocine—Face oedema—Prednisone—Crohn's disease	0.00442	0.0102	CcSEcCtD
Pentazocine—OPRK1—GPCR ligand binding—MLN—Crohn's disease	0.00438	0.00776	CbGpPWpGaD
Pentazocine—Irritability—Prednisone—Crohn's disease	0.00437	0.0101	CcSEcCtD
Pentazocine—Hypotension—Azathioprine—Crohn's disease	0.00437	0.01	CcSEcCtD
Pentazocine—Dry mouth—Mesalazine—Crohn's disease	0.00434	0.00998	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00433	0.00766	CbGpPWpGaD
Pentazocine—Confusional state—Mesalazine—Crohn's disease	0.00429	0.00987	CcSEcCtD
Pentazocine—Anaphylactic shock—Mesalazine—Crohn's disease	0.00426	0.00979	CcSEcCtD
Pentazocine—EBP—Metabolism—PLA2G4F—Crohn's disease	0.00425	0.00751	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CCR9—Crohn's disease	0.00424	0.00751	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00423	0.00749	CbGpPWpGaD
Pentazocine—Shock—Mesalazine—Crohn's disease	0.00419	0.00963	CcSEcCtD
Pentazocine—Tachycardia—Mesalazine—Crohn's disease	0.00415	0.00955	CcSEcCtD
Pentazocine—Hyperhidrosis—Mesalazine—Crohn's disease	0.00412	0.00946	CcSEcCtD
Pentazocine—Anorexia—Mesalazine—Crohn's disease	0.00406	0.00933	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00399	0.00706	CbGpPWpGaD
Pentazocine—Hypotension—Mesalazine—Crohn's disease	0.00398	0.00914	CcSEcCtD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00394	0.00697	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00394	0.00696	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—ACKR2—Crohn's disease	0.00391	0.00692	CbGpPWpGaD
Pentazocine—Sweating increased—Prednisone—Crohn's disease	0.00386	0.00887	CcSEcCtD
Pentazocine—Feeling abnormal—Azathioprine—Crohn's disease	0.00385	0.00885	CcSEcCtD
Pentazocine—Insomnia—Mesalazine—Crohn's disease	0.00385	0.00885	CcSEcCtD
Pentazocine—Paraesthesia—Mesalazine—Crohn's disease	0.00382	0.00879	CcSEcCtD
Pentazocine—Dyspnoea—Mesalazine—Crohn's disease	0.0038	0.00872	CcSEcCtD
Pentazocine—OPRD1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00379	0.00671	CbGpPWpGaD
Pentazocine—Somnolence—Mesalazine—Crohn's disease	0.00378	0.0087	CcSEcCtD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00371	0.00656	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—MLN—Crohn's disease	0.0037	0.00656	CbGpPWpGaD
Pentazocine—Decreased appetite—Mesalazine—Crohn's disease	0.0037	0.00851	CcSEcCtD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00366	0.00648	CbGpPWpGaD
Pentazocine—Constipation—Mesalazine—Crohn's disease	0.00364	0.00837	CcSEcCtD
Pentazocine—EBP—Metabolism—MTMR3—Crohn's disease	0.00361	0.00639	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00352	0.00623	CbGpPWpGaD
Pentazocine—Feeling abnormal—Mesalazine—Crohn's disease	0.00351	0.00806	CcSEcCtD
Pentazocine—OPRD1—GPCR ligand binding—CCR9—Crohn's disease	0.00346	0.00613	CbGpPWpGaD
Pentazocine—Hypersensitivity—Azathioprine—Crohn's disease	0.00344	0.00792	CcSEcCtD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00337	0.00597	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CCR6—Crohn's disease	0.00333	0.00589	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00332	0.00588	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—GPR65—Crohn's disease	0.00322	0.0057	CbGpPWpGaD
Pentazocine—Diarrhoea—Azathioprine—Crohn's disease	0.0032	0.00735	CcSEcCtD
Pentazocine—Hallucination—Prednisone—Crohn's disease	0.00315	0.00725	CcSEcCtD
Pentazocine—Hypersensitivity—Mesalazine—Crohn's disease	0.00314	0.00721	CcSEcCtD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00313	0.00555	CbGpPWpGaD
Pentazocine—OPRD1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.0031	0.00548	CbGpPWpGaD
Pentazocine—Dizziness—Azathioprine—Crohn's disease	0.00309	0.0071	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00308	0.00546	CbGpPWpGaD
Pentazocine—Asthenia—Mesalazine—Crohn's disease	0.00305	0.00702	CcSEcCtD
Pentazocine—OPRK1—GPCR ligand binding—CCR9—Crohn's disease	0.00304	0.00538	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00301	0.00533	CbGpPWpGaD
Pentazocine—Pruritus—Mesalazine—Crohn's disease	0.00301	0.00692	CcSEcCtD
Pentazocine—Vomiting—Azathioprine—Crohn's disease	0.00297	0.00683	CcSEcCtD
Pentazocine—Dermatitis—Azathioprine—Crohn's disease	0.00294	0.00677	CcSEcCtD
Pentazocine—Flushing—Prednisone—Crohn's disease	0.00294	0.00676	CcSEcCtD
Pentazocine—Headache—Azathioprine—Crohn's disease	0.00293	0.00673	CcSEcCtD
Pentazocine—Diarrhoea—Mesalazine—Crohn's disease	0.00291	0.0067	CcSEcCtD
Pentazocine—OPRM1—IL4-mediated signaling events—JAK2—Crohn's disease	0.00288	0.0051	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—MLN—Crohn's disease	0.00282	0.005	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—GPR65—Crohn's disease	0.00282	0.005	CbGpPWpGaD
Pentazocine—Dizziness—Mesalazine—Crohn's disease	0.00281	0.00647	CcSEcCtD
Pentazocine—EBP—Metabolism—FADS1—Crohn's disease	0.00281	0.00498	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CCR6—Crohn's disease	0.00281	0.00497	CbGpPWpGaD
Pentazocine—Nausea—Azathioprine—Crohn's disease	0.00278	0.00638	CcSEcCtD
Pentazocine—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00272	0.00481	CbGpPWpGaD
Pentazocine—Vomiting—Mesalazine—Crohn's disease	0.00271	0.00622	CcSEcCtD
Pentazocine—OPRD1—Signaling by GPCR—ACKR2—Crohn's disease	0.00271	0.00479	CbGpPWpGaD
Pentazocine—Dermatitis—Mesalazine—Crohn's disease	0.00268	0.00616	CcSEcCtD
Pentazocine—Headache—Mesalazine—Crohn's disease	0.00267	0.00613	CcSEcCtD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00265	0.0047	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00264	0.00468	CbGpPWpGaD
Pentazocine—EBP—Metabolism—GPX4—Crohn's disease	0.00263	0.00466	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00261	0.00461	CbGpPWpGaD
Pentazocine—Vision blurred—Prednisone—Crohn's disease	0.0026	0.00598	CcSEcCtD
Pentazocine—OPRM1—GPCR ligand binding—CCR9—Crohn's disease	0.00257	0.00454	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MLN—Crohn's disease	0.00257	0.00454	CbGpPWpGaD
Pentazocine—EBP—Metabolism—GCKR—Crohn's disease	0.00254	0.0045	CbGpPWpGaD
Pentazocine—Agitation—Prednisone—Crohn's disease	0.00254	0.00583	CcSEcCtD
Pentazocine—Nausea—Mesalazine—Crohn's disease	0.00253	0.00581	CcSEcCtD
Pentazocine—Vertigo—Prednisone—Crohn's disease	0.00248	0.0057	CcSEcCtD
Pentazocine—OPRK1—GPCR downstream signaling—MLN—Crohn's disease	0.00248	0.00438	CbGpPWpGaD
Pentazocine—Syncope—Prednisone—Crohn's disease	0.00247	0.00569	CcSEcCtD
Pentazocine—Loss of consciousness—Prednisone—Crohn's disease	0.00243	0.00558	CcSEcCtD
Pentazocine—OPRM1—GPCR ligand binding—GPR65—Crohn's disease	0.00239	0.00422	CbGpPWpGaD
Pentazocine—Hypertension—Prednisone—Crohn's disease	0.00238	0.00548	CcSEcCtD
Pentazocine—OPRK1—Signaling by GPCR—ACKR2—Crohn's disease	0.00237	0.0042	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00233	0.00412	CbGpPWpGaD
Pentazocine—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.0023	0.00406	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CCR6—Crohn's disease	0.00229	0.00406	CbGpPWpGaD
Pentazocine—Anaphylactic shock—Prednisone—Crohn's disease	0.00225	0.00518	CcSEcCtD
Pentazocine—OPRK1—Signaling by GPCR—MLN—Crohn's disease	0.00225	0.00398	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00223	0.00395	CbGpPWpGaD
Pentazocine—Shock—Prednisone—Crohn's disease	0.00222	0.00509	CcSEcCtD
Pentazocine—Tachycardia—Prednisone—Crohn's disease	0.0022	0.00505	CcSEcCtD
Pentazocine—Hyperhidrosis—Prednisone—Crohn's disease	0.00218	0.00501	CcSEcCtD
Pentazocine—Anorexia—Prednisone—Crohn's disease	0.00215	0.00494	CcSEcCtD
Pentazocine—OPRM1—GPCR downstream signaling—MLN—Crohn's disease	0.00209	0.0037	CbGpPWpGaD
Pentazocine—Insomnia—Prednisone—Crohn's disease	0.00204	0.00468	CcSEcCtD
Pentazocine—OPRM1—TCR Signaling Pathway—CD4—Crohn's disease	0.00203	0.00359	CbGpPWpGaD
Pentazocine—Paraesthesia—Prednisone—Crohn's disease	0.00202	0.00465	CcSEcCtD
Pentazocine—OPRD1—GPCR ligand binding—PTGER4—Crohn's disease	0.00202	0.00358	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CCR6—Crohn's disease	0.00201	0.00356	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.00201	0.00355	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00197	0.00348	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.00196	0.00347	CbGpPWpGaD
Pentazocine—Decreased appetite—Prednisone—Crohn's disease	0.00196	0.0045	CcSEcCtD
Pentazocine—Constipation—Prednisone—Crohn's disease	0.00193	0.00443	CcSEcCtD
Pentazocine—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.0019	0.00336	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.00187	0.00331	CbGpPWpGaD
Pentazocine—Feeling abnormal—Prednisone—Crohn's disease	0.00186	0.00427	CcSEcCtD
Pentazocine—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.00182	0.00322	CbGpPWpGaD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.00182	0.00322	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.00178	0.00315	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.00177	0.00314	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	0.00172	0.00304	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.0017	0.00301	CbGpPWpGaD
Pentazocine—Hypersensitivity—Prednisone—Crohn's disease	0.00166	0.00381	CcSEcCtD
Pentazocine—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	0.00165	0.00293	CbGpPWpGaD
Pentazocine—Asthenia—Prednisone—Crohn's disease	0.00162	0.00371	CcSEcCtD
Pentazocine—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	0.0016	0.00283	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	0.0016	0.00282	CbGpPWpGaD
Pentazocine—Pruritus—Prednisone—Crohn's disease	0.00159	0.00366	CcSEcCtD
Pentazocine—EBP—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.00159	0.00281	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	0.00156	0.00276	CbGpPWpGaD
Pentazocine—Diarrhoea—Prednisone—Crohn's disease	0.00154	0.00354	CcSEcCtD
Pentazocine—OPRD1—Signaling Pathways—MLN—Crohn's disease	0.00152	0.00268	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.0015	0.00265	CbGpPWpGaD
Pentazocine—Dizziness—Prednisone—Crohn's disease	0.00149	0.00342	CcSEcCtD
Pentazocine—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.00145	0.00257	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	0.00145	0.00257	CbGpPWpGaD
Pentazocine—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00145	0.00256	CbGpPWpGaD
Pentazocine—Vomiting—Prednisone—Crohn's disease	0.00143	0.00329	CcSEcCtD
Pentazocine—Dermatitis—Prednisone—Crohn's disease	0.00142	0.00326	CcSEcCtD
Pentazocine—Headache—Prednisone—Crohn's disease	0.00141	0.00324	CcSEcCtD
Pentazocine—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	0.0014	0.00248	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	0.00139	0.00245	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.00135	0.00239	CbGpPWpGaD
Pentazocine—Nausea—Prednisone—Crohn's disease	0.00134	0.00308	CcSEcCtD
Pentazocine—OPRK1—Signaling Pathways—MLN—Crohn's disease	0.00133	0.00235	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.00132	0.00233	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.0013	0.0023	CbGpPWpGaD
Pentazocine—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00127	0.00225	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.00122	0.00217	CbGpPWpGaD
Pentazocine—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00122	0.00216	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.00122	0.00215	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.00121	0.00214	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.00118	0.0021	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.00118	0.00208	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.00115	0.00203	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00114	0.00202	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.00114	0.00201	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.00112	0.00199	CbGpPWpGaD
Pentazocine—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.0011	0.00194	CbGpPWpGaD
Pentazocine—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.00107	0.0019	CbGpPWpGaD
Pentazocine—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00107	0.0019	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.00106	0.00188	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.00105	0.00186	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.00104	0.00184	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.00103	0.00183	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.00103	0.00182	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.00101	0.00178	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	0.001	0.00177	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—GPR65—Crohn's disease	0.000976	0.00173	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	0.000973	0.00172	CbGpPWpGaD
Pentazocine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000971	0.00172	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000961	0.0017	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000941	0.00166	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR9—Crohn's disease	0.000921	0.00163	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	0.000909	0.00161	CbGpPWpGaD
Pentazocine—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000905	0.0016	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000898	0.00159	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL3—Crohn's disease	0.000883	0.00156	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000873	0.00154	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GPR65—Crohn's disease	0.000856	0.00152	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000854	0.00151	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	0.000853	0.00151	CbGpPWpGaD
Pentazocine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000852	0.00151	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000851	0.00151	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000846	0.0015	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000825	0.00146	CbGpPWpGaD
Pentazocine—EBP—Metabolism—ALB—Crohn's disease	0.000809	0.00143	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.000778	0.00138	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL3—Crohn's disease	0.000774	0.00137	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000768	0.00136	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000749	0.00133	CbGpPWpGaD
Pentazocine—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.00074	0.00131	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GPR65—Crohn's disease	0.000724	0.00128	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000721	0.00128	CbGpPWpGaD
Pentazocine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00072	0.00127	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PTGS2—Crohn's disease	0.000708	0.00125	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000697	0.00123	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR6—Crohn's disease	0.000696	0.00123	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000681	0.00121	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL3—Crohn's disease	0.000655	0.00116	CbGpPWpGaD
Pentazocine—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	0.000648	0.00115	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000633	0.00112	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RBX1—Crohn's disease	0.000629	0.00111	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.000619	0.00109	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000613	0.00108	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR6—Crohn's disease	0.00061	0.00108	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000597	0.00106	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RBX1—Crohn's disease	0.000552	0.000976	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	0.000552	0.000976	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000548	0.00097	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	0.000542	0.00096	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	0.000537	0.000951	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	0.000535	0.000947	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL3—Crohn's disease	0.000522	0.000923	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR6—Crohn's disease	0.000516	0.000913	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000505	0.000894	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	0.000505	0.000893	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	0.000484	0.000856	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	0.000469	0.00083	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RBX1—Crohn's disease	0.000466	0.000825	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000458	0.000811	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.000458	0.00081	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL3—Crohn's disease	0.000457	0.00081	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000457	0.000809	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000454	0.000803	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	0.000442	0.000783	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	0.000436	0.000771	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000418	0.00074	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	0.000416	0.000736	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000409	0.000724	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	0.000402	0.000711	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	0.000401	0.000709	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000396	0.000702	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	0.000395	0.000699	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL3—Crohn's disease	0.000387	0.000684	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	0.000382	0.000676	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.00038	0.000672	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000374	0.000662	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000366	0.000649	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	0.000365	0.000647	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	0.000365	0.000645	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	0.000346	0.000613	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000339	0.000601	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000339	0.0006	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	0.000333	0.000589	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000323	0.000572	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	0.00032	0.000567	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.00031	0.000548	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000308	0.000545	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000293	0.000518	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000281	0.000498	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000271	0.000479	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TYK2—Crohn's disease	0.000257	0.000456	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JAK2—Crohn's disease	0.000246	0.000435	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TYK2—Crohn's disease	0.000226	0.0004	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	0.000224	0.000397	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JAK2—Crohn's disease	0.000215	0.000381	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—Crohn's disease	0.000213	0.000377	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	0.000197	0.000348	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TYK2—Crohn's disease	0.000191	0.000338	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—Crohn's disease	0.000187	0.000331	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JAK2—Crohn's disease	0.000182	0.000322	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—Crohn's disease	0.00018	0.000319	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	0.000166	0.000294	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—Crohn's disease	0.000158	0.00028	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—Crohn's disease	0.000158	0.00028	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—Crohn's disease	0.000134	0.000236	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—Crohn's disease	0.000126	0.000223	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—Crohn's disease	0.00011	0.000195	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—Crohn's disease	9.33e-05	0.000165	CbGpPWpGaD
